Status: Recruiting
PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections
A multicenter, national, prospective, observational pharmacological study of patients with difficult-to-treat Gram-negative infections treated with ceftazidime/avibactam (CAZ/AVI) or cefiderocol (CEF) monotherapy or combination therapy with ceftazidime/avibactam associated with fosfomycin (FOS) or cefiderocol associated with fosfomycin.
Participants needed: 120
Trial details
Biological sex: AllType: ObservationalSponsor: University of BolognaUpdated: Oct 21, 2024Locations: 11
Eligibility criteria
Patients with infection due to a difficult-to-treat Gram-negative bacteria treat... [+1]
Premature newborns [+4]